Kosdrug Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 18-05-2024
- Paid Up Capital ₹ 0.57 M
as on 18-05-2024
- Company Age 68 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.65 M
as on 18-05-2024
- Revenue 100.14%
(FY 2016)
- Profit -8074.14%
(FY 2016)
- Ebitda -97.50%
(FY 2016)
- Net Worth -7.62%
(FY 2016)
- Total Assets 106.05%
(FY 2016)
About Kosdrug
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.57 M.
The company currently has active open charges totaling ₹0.65 M.
Anshu Chawla, Amit Chawla, and Amrit Chawla serve as directors at the Company.
- CIN/LLPIN
U74899DL1956PTC002728
- Company No.
002728
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Nov 1956
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Central Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Kosdrug Private Limited offer?
Kosdrug Private Limited offers a wide range of products and services, including Surgical & ICU Equipments, Oxygen Mask, Ventilator Parts & Consumables, Infusion Syringes & Supplies, Medical Tubes, Forceps & Graspers, Cardiac Surgery Equipment, Disposable Cannulas.
Who are the key members and board of directors at Kosdrug?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anshu Chawla  | Director | 17-Nov-2007 | Current |
| Amit Chawla | Director | 25-Mar-2011 | Current |
| Amrit Chawla | Director | 17-Nov-2007 | Current |
Financial Performance and Corporate Structure Insights of Kosdrug.
Kosdrug Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 100.14% increase. The company also saw a substantial fall in profitability, with a 8074.14% decrease in profit. The company's net worth dipped by a decrease of 7.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kosdrug?
In 2016, Kosdrug had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 13 Sep 1976 | ₹0.20 M | Open |
Indian Bank Creation Date: 11 Feb 1976 | ₹0.20 M | Open |
National & Grindlays Bank Ltd. Creation Date: 11 Jun 1975 | ₹0.10 M | Open |
How Many Employees Work at Kosdrug?
Kosdrug has a workforce of 1 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kosdrug, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kosdrug's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
